AyurMaya Capital Management Company, LP - 21 May 2025 Form 4 Insider Report for ALUMIS INC. (ALMS)

Reporting relationship: Director, Other*, 10%+ Owner
Issuer ticker: ALMS
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2025, 16:20:51 UTC
Prior SEC filing: 03 Jul 2024
Source filing: View source filing
Reporting owner signature: AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member

Key filing fact

AyurMaya Capital Management Company, LP filed Form 4 for ALUMIS INC. (ALMS) on 23 May 2025.

Key facts

This page summarizes AyurMaya Capital Management Company, LP's Form 4 filing for ALUMIS INC. (ALMS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2025, 16:20.

Change

Previous filing in this sequence was filed on 03 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001975990 Primary reporting owner

AyurMaya Capital Management Company, LP

Relationship: Director, Other*, 10%+ Owner
Address: 3 PLEASANT STREET, SUITE 400, PORTSMOUTH
Signature: AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member
Signature date: 23 May 2025

CIK 0001548144

GOEL DAVID E.

Relationship: Director, Other*, 10%+ Owner
Address: 3 PLEASANT STREET, SUITE 400, PORTSMOUTH
Signature: /s/ David E. Goel
Signature date: 23 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMS transaction

Common Stock, par value $0.0001 per share ("Common Stock")

Award

Transaction value
Shares: +4,493,741
Change %: +42%
Price
Shares after: 15,139,707
Date: 21 May 2025
Ownership: See footnotes
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among ACELYRIN, Inc., a Delaware corporation ("ACELYRIN") and Alumis Inc., a Delaware corporation (the "Issuer") and the other parties thereto (the "Merger Agreement"), the shares of Common Stock were issued to the AyurMaya Fund (as defined below) in exchange for 9,334,735 shares of ACELYRIN common stock on the effective date of the merger contemplated by the Merger Agreement.

Footnote F2

Reflects the estimated number of shares of Common Stock to be issued to the AyurMaya Fund (as defined below) pursuant to the Merger Agreement. The Reporting Persons will file an amendment to this Form 4 to the extent the actual number of shares of Common Stock issued differs in any material respect from the number reported in column (4).

Footnote F3

The securities reported herein are held by AyurMaya Capital Management Fund, LP (the "AyurMaya Fund"). AyurMaya Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager.

Footnote F4

The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.

SEC remarks

The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Alan Colowick, Senior Managing Director of Matrix Capital Management Company LP, an affiliate of the Investment Manager, currently serves on the board of directors of the Issuer.